Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Characterizing Cell-Line-Specific Genetic Interaction Networks to Reveal Heterogeneity and Personalized Vulnerabilities in Glioblastoma
FY 2025-26
Summary
Glioblastoma (GBM) is the most aggressive brain cancer in adults and remains extremely difficult to treat. A major reason for this challenge is that GBM tumours vary widely at the molecular level, both between patients and even within a single tumour. This complexity makes it hard to develop treatments that can reliably improve patient outcomes. To find better treatment strategies, researchers are beginning to look not just at individual genes, but at how genes work together inside cancer cells. Sometimes, cancer cells can tolerate the loss of a single gene, but if a second specific gene is also disrupted, the cell can no longer survive. This is called a synthetic lethal interaction, and it can reveal hidden weaknesses that may be targeted with drugs to kill cancer cells. However, these interactions have never been systematically mapped across different GBM cell models (lab-grown GBM cells), and it remains unclear how much they vary from one GBM tumour to another. In this project, I will use large-scale genomic data to create interaction maps for many GBM models, focusing on tumour suppressor genes that commonly lose their function in cancer. I will compare these maps to see which interactions are shared across GBM and which are unique to specific models. I will then test a small number of promising interactions in the lab by blocking a gene–using either existing drugs or gene-editing tools–to see whether this selectively kills GBM cells that carry a specific genetic change. This work will provide the first systematic view of how genetic vulnerabilities differ across GBM. By identifying both shared and unique weak points in GBM, this research may help guide the development of more effective and individualized treatment for people facing this highly aggressive cancer.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572768
Name
Makarova Karina
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing Cell-Line-Specific Genetic Interaction Networks to Reveal Heterogeneity and Personalized Vulnerabilities in Glioblastoma
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Brain Cancer; Cancer Genomics; Cancer Vulnerabilities; Genetic Interactions; Genetic Network Analysis; Glioblastoma; Precision Oncology; Synthetic Lethality; Tumour Heterogeneity; Tumour Suppressor Genes
Abstract
Glioblastoma (GBM) is the most aggressive brain cancer in adults and remains extremely difficult to treat. A major reason for this challenge is that GBM tumours vary widely at the molecular level, both between patients and even within a single tumour. This complexity makes it hard to develop treatments that can reliably improve patient outcomes. To find better treatment strategies, researchers are beginning to look not just at individual genes, but at how genes work together inside cancer cells. Sometimes, cancer cells can tolerate the loss of a single gene, but if a second specific gene is also disrupted, the cell can no longer survive. This is called a synthetic lethal interaction, and it can reveal hidden weaknesses that may be targeted with drugs to kill cancer cells. However, these interactions have never been systematically mapped across different GBM cell models (lab-grown GBM cells), and it remains unclear how much they vary from one GBM tumour to another. In this project, I will use large-scale genomic data to create interaction maps for many GBM models, focusing on tumour suppressor genes that commonly lose their function in cancer. I will compare these maps to see which interactions are shared across GBM and which are unique to specific models. I will then test a small number of promising interactions in the lab by blocking a gene–using either existing drugs or gene-editing tools–to see whether this selectively kills GBM cells that carry a specific genetic change. This work will provide the first systematic view of how genetic vulnerabilities differ across GBM. By identifying both shared and unique weak points in GBM, this research may help guide the development of more effective and individualized treatment for people facing this highly aggressive cancer.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Makarova, Karina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~